Kewaunee Scientific (NASDAQ:KEQU) Announces Quarterly Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) issued its quarterly earnings data on Wednesday. The technology company reported $1.09 earnings per share (EPS) for the quarter, Zacks reports. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Kewaunee Scientific Stock Up 4.3 %

Shares of NASDAQ KEQU traded up $2.02 during mid-day trading on Wednesday, reaching $49.20. 26,237 shares of the company’s stock were exchanged, compared to its average volume of 25,215. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. The business has a fifty day simple moving average of $59.42 and a 200 day simple moving average of $47.95. Kewaunee Scientific has a twelve month low of $29.95 and a twelve month high of $71.33. The firm has a market capitalization of $141.30 million, a price-to-earnings ratio of 7.80 and a beta of 0.71.

Insider Buying and Selling

In other news, CEO Thomas David Hull III sold 1,368 shares of the business’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $60.08, for a total value of $82,189.44. Following the sale, the chief executive officer now directly owns 41,129 shares in the company, valued at $2,471,030.32. The trade was a 3.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Donald T. Gardner III sold 1,257 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $59.26, for a total value of $74,489.82. Following the transaction, the chief financial officer now owns 21,358 shares of the company’s stock, valued at approximately $1,265,675.08. The trade was a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 11,994 shares of company stock valued at $729,430. 14.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Kewaunee Scientific

An institutional investor recently raised its position in Kewaunee Scientific stock. Bank of America Corp DE raised its holdings in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 2,605.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 460 shares of the technology company’s stock after acquiring an additional 443 shares during the quarter. Bank of America Corp DE’s holdings in Kewaunee Scientific were worth $28,000 at the end of the most recent reporting period. Institutional investors own 32.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.